Lutris, Pharma Lutris Pharma Announces Publication of Positive Data From Its Phase 1/ 2 Trial of LUT014 to Treat Radiation Dermatitis in Patients with Breast Cancer Published on 08/07/2025 at 18:04 | prnewswire.co.uk Lutris Pharma Israel California New York View original content:https://www.prnewswire.co.uk/news-releases/lutris-pharma-announces-publication-of-positive-data-from-its-phase-12-trial-of-lut014-to-treat-radiation-dermatitis-in-patients-with-breast-cancer-302066543.html en | boerse | 67986932 |
